Advertisement

Alteration of Growth Hormone Secretion in Aging: Peripheral Effects

  • Thierry Abribat
  • Nathalie Deslauriers
  • Isabelle Reeves
  • Dominique R. Garrel
  • Paul Brazeau
Conference paper
Part of the Serono Symposia USA Norwell, Massachusetts book series (SERONOSYMP)

Abstract

In humans and animals, the aging process is associated with major endocrine changes. The view that these changes are responsible for the aging of an organism is undoubtedly oversimplistic (1). However, strong evidence indicates that they participate in the progressive loss of important physiologic functions, such as reproduction, immune function, maintenance of somatic anabolism, thyroid function, and so forth (2). In this process, synthesis and secretion of pituitary hormones are differently affected (3), being either increased (prolactin) or decreased (gonadotropins and growth hormone). Among endocrine alterations that develop early in aging, the blunting of basal and stimulated growth hormone (GH) secretion has been extensively documented in human and animal models (4–9). Numerous experimental observations of the aging somatotropic axis by our laboratory and others support the view that these alterations originate at the level of GH regulatory factors. Some important mechanisms that lead to this impairment are reviewed in the first part of this chapter.

Keywords

Growth Hormone Growth Hormone Secretion Growth Hormone Release Factor Decrease Growth Hormone Secretion Growth Hormone Release Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hayflick C. Theories of biological aging. Exp Gerontol 1985;20:145–59.PubMedCrossRefGoogle Scholar
  2. 2.
    Meites J, Goya R, Takahashi S. Why the neuroendocrine system is important in aging processes. Exp Gerontol 1987;22:1–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Zbuzek V, Arnetz BB, Eneroth P, Zbuzek VK. Age-related differences in concomitant hormone release from the superfused rat adenopituitary. Gerontology 1991;37:253–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Finkelstein JW, Roffwang P, Boyar RM, Kream J, Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972;35:665–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Ho KJ, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Shibasaki T, Shizume K, Nakahara M, et al. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 1984;58:212–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Sonntag WE, Steger RW, Forman LJ, Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 1980;107:1875–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Ceda G, Valenti G, Butterini U, Hoffman AR. Diminished pituitary response to growth hormone-releasing factor in aging male rats. Endocrinology 1986;118:2109–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Deslauriers N, Gaudreau P, Abribat T, Renier G, Petitclerc D, Brazeau P. Dynamics of growth hormone responsiveness to growth hormone-releasing factor in aging rats: peripheral and central influences. Neuroendocrinology 1991;53:439–46.PubMedCrossRefGoogle Scholar
  10. 10.
    Rudmann D. Growth hormone, body composition, and aging. J Am Geriatr Soc 1985;33:800–7.Google Scholar
  11. 11.
    Rudmann D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1–6.CrossRefGoogle Scholar
  12. 12.
    Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990:519–27.Google Scholar
  13. 13.
    Weksler ME. Immune senescence in man. In: Fabris N, ed. Immunology and ageing. The Hague: Martinus Nijhoff, 1982:165–73.Google Scholar
  14. 14.
    Goodson WH, Hunt TK. Wound healing and aging. J Invest Dermatol 1979;73:88–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Khansari DN, Gustad T. Effects of long-term, low dose growth hormone therapy on immune function and life expectancy of mice. Mech Ageing Dev 1991;57:87–100.PubMedCrossRefGoogle Scholar
  16. 16.
    Wiedermann CJ, Niedermühlbichler M, Beimpold H. Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 1991;164:1017–20.PubMedCrossRefGoogle Scholar
  17. 17.
    Sonntag WE, Hylka VW, Meites J. Growth hormone restores protein synthesis in skeletal muscle of old male rats. J Gerontol 1985;40:689–94.PubMedGoogle Scholar
  18. 18.
    Jorgensen PH, Andreassen TT. A dose-response study of the effects of biosynthetic human growth hormone on formation and strengh of granulation tissue. Endocrinology 1987;121:1637–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Garrel DR, Gaudreau P, Zhang L, Reeves I, Brazeau P. Chronic administration of growth hormone-releasing factor increases wound strength and collagen maturation in granulation tissue. J Surg Res 1991;51:297–302.PubMedCrossRefGoogle Scholar
  20. 20.
    Mueller RV, Spencer EM, Sommer A, et al. The role of IGF-I and IGFBP3 in wound healing. In: Spencer EM, ed. Modern concepts of insulin-like growth factors. Elsevier, 1991:185–92.Google Scholar
  21. 21.
    Ullman M, Oldfors A. Effects of growth hormone on skeletal muscle, I. Studies on normal adult rats. Acta Physiol Scand 1989;135:531–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Ullman U, Alameddine H, Skottner A, Oldfors A. Effects of growth hormone on skeletal muscle, II. Studies on regeneration and denervation in adult rats. Acta Physiol Scand 1989;135:537–43.PubMedCrossRefGoogle Scholar
  23. 23.
    Guillemin R, Brazeau P, Bohlen P, et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982; 218:585–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Brazeau P, Vale W, Burgus R, et al. A hypothalamic polypeptide that inhibits the secretion of pituitary growth hormone. Science 1973;179:77–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Gick GG, Zeytin FN, Brazeau P, Ling NC, Esch FS, Bancroft FC. Growth hormone-releasing factor regulates growth hormone mRNA in primary cultures of rat pituitary cells. Proc Natl Acad Sci USA 1984;81:1553–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Martinoli MG, Ouellet J, Rhéaume E, Pelletier G. Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization. Neuroendocrinology 1991;54:607–15.PubMedCrossRefGoogle Scholar
  27. 27.
    Ghigo E, Goffî S, Nicolosi M, et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990;71:1481–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Coiro V, Volpi R, Cavazzini U, et al. Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline. J Gerontol 1991:M155–8.Google Scholar
  29. 29.
    Walker RF, Yank SW, Bereu BB. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Life Sci 1991;49:1499–504.PubMedCrossRefGoogle Scholar
  30. 30.
    De Gennaro Colonna V, Zoli M, Cocchi D, et al. Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. Peptides 1989;10:705–8.CrossRefGoogle Scholar
  31. 31.
    Morimoto N, Kawakami F, Makino S, Chihara K, Hasegawa M, Ibata Y. Age-related changes in growth hormone-releasing factor and somatostatin in the rat hypothalamus. Neuroendocrinology 1988;47:459–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Bando H, Zhang C, Takada Y, Yamasaki R, Saito S. Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men. Acta Endocrinol (Copenh) 1991;124:31–6.Google Scholar
  33. 33.
    De Gennaro Colonna V, Fidone F, Cocchi D, Müller EE. The negative feedback effect of growth hormone-releasing hormone is not evident in aged rats [Abstract]. 9th Int Cong Endocrinol, Nice, France, Aug. 30-Sept. 5, 1992:20.04.011.Google Scholar
  34. 34.
    Robberecht P, Gillard M, Waelbroeck M, Camus JC, De Neef P, Christophe J. Decreased stimulation of adenylate cyclase by growth hormone-releasing factor in the anterior pituitary of old rats. Neuroendocrinology 1986;44: 429–32.PubMedCrossRefGoogle Scholar
  35. 35.
    Abribat T, Boulanger L, Gaudreau P. Characterization of [125I-Tyr10] human growth hormone-releasing factor (1–44) amide binding to rat pituitary: evidence for high and low affinity classes of sites. Brain Res 1990;528:291–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Abribat T, Deslauriers N, Brazeau P, Gaudreau P. Alterations of pituitary growth hormone-releasing factor binding sites in aging rats. Endocrinology 1991;128:633–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Abribat T, Finkelstein JA, Gaudreau P. Alteration of somatostatin but not growth hormone-releasing factor pituitary binding sites in obese Zucker rats. Regul Pept 1991;36:263–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Lefrançois L, Abribat T, Boulanger L, Gaudreau P. Effect of 5’-guanylylimi-dodiphosphate and sulfhydryl-modifying reagents on [125I-Tyr10] h growth hormone-releasing factor (1–44)NH2 binding in rat pituitary. Society for Neuroscience, New Orleans, Louisiana, Nov. 1991.Google Scholar
  39. 39.
    Parenti M, Cocchi D, Ceresoli G, Marcozzi C, Müller EE. Age-related changes of growth hormone secretory mechanisms in the rat pituitary gland. J Endocrinol 1991;131:251–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Parenti M, Dall’Ara A, Rusconi L, Cocchi D, Müller EE. Different regulation of growth hormone-releasing factor-sensitive adenylate cyclase in the anterior pituitary of young and aged rats. Endocrinology 1987;121:1649–53.PubMedCrossRefGoogle Scholar
  41. 41.
    Sonntag WE, Boyd RL, Booze RM. Somatostatin gene expression in hypothalamus and cortex of aging male rats. Neurobiol Aging 1990;11:409–16.PubMedCrossRefGoogle Scholar
  42. 42.
    Ge F, Tsagarakis S, Rees LH, Besser GM, Grossman A. Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic explants. J Endocrinol 1989;123:53–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Sonntag WE, Gottschall PE, Meites J. Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro. Brain Res 1986;380: 229–34.PubMedCrossRefGoogle Scholar
  44. 44.
    Spik K, Sonntag WE. Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology 1989;50:489–94.PubMedCrossRefGoogle Scholar
  45. 45.
    Sonntag WE, Forman LJ, Miki N, et al. Effects of CNS active drugs and somatostatin antiserum on growth hormone release in young and old male rats. Neuroendocrinology 1981;33:73–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Clemmons DR, Van Wyk JJ. Factors controlling blood concentration of somatomedin C. J Clin Endocrinol Metab 1984;13:113–43.CrossRefGoogle Scholar
  47. 47.
    Bowsher RR, Lee W, Apathy JM, O’Brien PJ, Ferguson AL, Henry DP. Measurement of insulin-like growth factor II in physiological fluids and tissues, I. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 1991;128:805–14.PubMedCrossRefGoogle Scholar
  48. 48.
    Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Hattori N, Kurahachi H, Ikekubo K, et al. Effect of sex and age on serum GH binding protein levels in normal adults. Clin Endocrinol (Oxf) 1991–35:295–7.Google Scholar
  50. 50.
    Hammerman MR. Insulin-like growth factors and aging. Endocrinol Metab Clin 1987;16:995–1011.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Thierry Abribat
  • Nathalie Deslauriers
  • Isabelle Reeves
  • Dominique R. Garrel
  • Paul Brazeau

There are no affiliations available

Personalised recommendations